|
|
Volumn 215, Issue 12, 2017, Pages 1789-1798
|
|
Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults
a
b
c
d
e
f
f
f
f
f
f
|
|
Author keywords
Ebola; rVSV G ZEBOV GP; safety.; vaccine
|
|
Indexed keywords
EBOLA VACCINE;
PLACEBO;
RECOMBINANT VESICULAR STOMATITIS VIRUS ZAIRE EBOLA VIRUS ENVELOPE GLYCOPROTEIN VACCINE;
UNCLASSIFIED DRUG;
ENVELOPE GLYCOPROTEIN, EBOLA VIRUS;
RECOMBINANT VACCINE;
VIRUS ENVELOPE PROTEIN;
ADULT;
AGED;
ARTHRALGIA;
ARTHRITIS;
ARTICLE;
BLISTER;
CAUSE OF DEATH;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TOLERABILITY;
EBOLA HEMORRHAGIC FEVER;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FEVER;
HUMAN;
INFORMED CONSENT;
INJECTION SITE PAIN;
INJECTION SITE REACTION;
INJECTION SITE REDNESS;
INJECTION SITE SWELLING;
MALE;
MIDDLE AGED;
PHASE 1 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
POPULATION RESEARCH;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RASH;
RECURRENT DISEASE;
SIDE EFFECT;
TEMPERATURE MEASUREMENT;
UNITED STATES;
VACCINATION;
YOUNG ADULT;
ADOLESCENT;
CLINICAL TRIAL;
EBOLAVIRUS;
HEMORRHAGIC FEVER, EBOLA;
IMMUNOLOGY;
NORMAL HUMAN;
PROCEDURES;
STATISTICS AND NUMERICAL DATA;
VESICULAR STOMATITIS;
ADOLESCENT;
ADULT;
AGED;
DOUBLE-BLIND METHOD;
EBOLA VACCINES;
EBOLAVIRUS;
FEMALE;
HEALTHY VOLUNTEERS;
HEMORRHAGIC FEVER, EBOLA;
HUMANS;
MALE;
MIDDLE AGED;
VACCINATION;
VACCINES, SYNTHETIC;
VESICULAR STOMATITIS;
VIRAL ENVELOPE PROTEINS;
YOUNG ADULT;
|
|
EID: 85022326921
PISSN: 00221899
EISSN: 15376613
Source Type: Journal
DOI: 10.1093/infdis/jix189 Document Type: Article |
|
Times cited : (66)
|
|
References (13)
|
